In Brief Clovis et al. describe the mechanism through which spinal V2a interneurons are specified. They find that the bestknown marker for V2a interneurons, Chx10, is the major determinant of V2a fate specification. Chx10 upregulates the expression of V2a interneuron genes while suppressing the expression of nonV2a interneuron and motor neuron genes.
INTRODUCTION
During embryonic organogenesis, many cell types are born in a spatially and temporally controlled manner to form a functional tissue. One of the most fundamental questions in developmental biology is how closely related cell types are produced from similar progenitors and yet acquire and maintain completely distinct cell identities during later stages of organogenesis. This relatively poorly understood process involves intricate gene regulatory networks that operate during sequential steps of cell fate commitment, specification, and differentiation.
The gene regulatory networks for motor neurons (MNs) and V2a interneurons (V2aINs) provide an ideal platform to address this topic. The morphogen Sonic hedgehog (shh) is secreted from the notochord and floor plate and patterns neuroepithelial cells along the dorso-ventral axis, leading to the formation of the two neighboring progenitor domains, the pMN and p2 domains ( Figure 1A ) (Catela et al., 2015; Lee and Pfaff, 2001) . Progenitor cells in the pMN and p2 domains produce MNs and V2aINs, respectively. While pMN cells upregulate the LIM-homeodomain (HD) transcription factors Isl1 and Lhx3 right before differentiation to MNs, p2 cells upregulate Lhx3, but not Isl1, shortly before cell-cycle exit ( Figure 1A ) (Ericson et al., 1992; Pfaff et al., 1996; . Isl1 and Lhx3 form a hexameric complex with a self-dimerizing cofactor NLI, herein referred to as the Isl1-Lhx3-complex (also known as the MN-hexamer; Figure 1A ) (Lee et al., 2008; Lee and Pfaff, 2003; Seo et al., 2015; Thaler et al., 2002) . The Isl1-Lhx3-complex directly controls a wide range of MN genes and plays crucial roles in the fate specification of MNs (Cho et al., 2014; Lee et al., 2004 Lee et al., , 2008 Lee et al., , 2012 Lee et al., , 2013 Lee and Pfaff, 2003; Mazzoni et al., 2013; Thaler et al., 2002; Thiebes et al., 2015) . The misexpression of Lhx3 alone drives formation of ectopic V2aINs marked by Chx10 in the developing spinal cord (Tanabe et al., 1998; Thaler et al., 2002) . Lhx3 also binds to NLI and forms a tetrameric complex herein referred to as Lhx3-complex (also known as the V2-tetramer; Figure 1A ) (Joshi et al., 2009; Thaler et al., 2002) . It has remained unclear whether the Lhx3-complex directly induces the expression of an array of V2aIN genes, similarly to the Isl1-Lhx3-complex, or whether it indirectly triggers V2aIN fate by upregulating other transcription factors that serve as its downstream effectors to induce V2a identity. The segregation of pMN and p2 domains is initiated by the cross-repressive actions of two transcription factors, Olig2 and Irx3, in the progenitor cells (Lee and Pfaff, 2001; Lu et al., 2002; Novitch et al., 2001; Zhou and Anderson, 2002) . Interestingly, pMN cells and newborn MNs maintain cell fate plasticity and can switch their fate into V2aINs when the MN pathway is dysregulated (Arber et al., 1999; Lee et al., 2008; Lu et al., 2002; Song et al., 2009; Zhou and Anderson, 2002) . These results strongly suggest that the mechanisms that separate MN and V2aIN identities continue to operate even after the progenitor cells are committed to MN or V2aIN fate. However, the precise regulatory mechanisms that consolidate V2aIN fate after cell-cycle exit have yet to be clarified.
While Lhx3 triggers the V2aIN fate specification, it is also expressed in MNs , thus warranting additional mechanisms to block erroneous activation of MN genes in differentiating V2aINs. It is possible that Lhx3 induces the expression of other effector transcription factors only in V2aINs, rather than directly upregulating the expression of V2aIN genes. Those V2a-specific transcription factors may then activate the expression of V2aIN genes. One such candidate is Chx10 (Vsx2), a paired HD transcription factor with the CVC domain. Chx10 expression, restricted to V2aINs within the developing spinal cord (Ericson et al., 1997) , is induced ectopically by the misexpression of Lhx3 in the neural tube (Tanabe et al., 1998; Thaler et al., 2002) . Chx10 is the best-known marker of V2aINs. However, the role of Chx10 in V2aIN specification and differentiation has not been explored.
In this report, we show that Chx10 promotes V2aIN fate by actively promoting V2a identity, while simultaneously suppressing non-V2aIN and MN identities. We further show that Chx10 employs two distinct modes of action in promoting V2a fate and suppressing MN identity. While Chx10 functions as a transcriptional repressor to activate V2aIN program, it acts as a DNA-binding competitor of the Isl1-Lhx3-complex in suppressing the expression of MN genes. Our findings represent a generalizable phenomenon most likely occurring during the organogenesis of many tissues that require segregation of cell fates derived from related progenitor pools during development.
RESULTS

Chx10
Mediates the Activity of Lhx3 in Inducing V2aIN Fate To test whether Chx10 contributes to Lhx3-directed induction of V2aIN identity, we devised a short-hairpin RNA (shRNA) construct targeting the 3 0 UTR region of the chick Chx10 transcript ( Figure 1B) . We misexpressed Lhx3 with shRNA-Chx10 or shRNA-vector control in neural progenitors of the developing spinal cord by using in ovo electroporation and monitored the formation of ectopic V2aINs 3 days post-electroporation. Coelectroporation of Lhx3 with shRNA-Chx10 led to a 17.5% reduction of Chx10 + cells in the electroporated side compared to the control side ( Figures 1B and 1C) , confirming effective knockdown efficiency of shRNA-Chx10. The V2aIN marker Sox14 expression was induced as soon as V2aINs were born, and Sox14 was co-expressed with Chx10 in most V2aINs (Figure S1A) . The V2aIN marker Shox2 has been reported to be expressed in $60% of V2aINs at post-natal day (P)0 (Dougherty et al., 2013; Joshi et al., 2009; Thaler et al., 2002) . We found that Lhx3 triggers the ectopic expression of Chx10, Sox14, and Shox2 ( Figure 1B) . Quantification revealed an increase of Figure 1C ). Lhx3 also induced the expression of vesicular gluatamate transporter 2 (VGluT2), a marker of glutamatergic neurons ( Figure 1B ). Thus, Lhx3 is sufficient to induce the formation of V2aINs in spinal neural progenitors. With shRNA-Chx10, however, Lhx3 failed to trigger the expression of other V2a marker genes, such as Sox14, Shox2, and VGluT2 ( Figures 1B and 1C ). Lhx3 did not trigger ectopic MN formation with shRNA-Chx10 or shRNA-vector control ( Figure S1B ). These data suggest that Chx10 is a crucial mediator of the activity of Lhx3 to induce V2aIN fate ( Figure 1D ).
Development of V2aINs and MNs Is Perturbed in Chx10-Null Mice
To elucidate the role of Chx10 in the developing spinal cord, we analyzed Chx10 orJ/orJ mice . Immunohistochemical analyses with a Chx10 antibody, which detects the N-terminal region of the mouse Chx10 protein, confirmed that the expression of Chx10 protein is reduced to undetectable levels in Chx10 orJ/orJ spinal cords (Figures 2A and S2A ).
As Chx10 is the best-known marker of V2aINs and the production of Chx10 transcripts should not be affected by the point mutation in the Figure S2C ).
The number of cells expressing Gata3, a V2b interneuron marker, or Evx1, a V0 interneuron marker, did not change ( Figure S2D ), suggesting that the loss of Chx10 did not lead to a fate conversion to V2b or V0 interneurons. Sox14 + V2aINs remained to be reduced in E13.5 and E15.5 Chx10 orJ/orJ embryos (Figures S2G and S2H) . In Chx10-deficient mice, several MNs were found in the motor axonal track outside of the spinal cord (Figures 2A and S2E ), indicating that some MN soma abnormally escaped the spinal cord via the motor exit point in the absence of Chx10. The MN marker vesicular acetylcholine transporter (VAChT) was expressed more strongly in a wider area in Chx10-null mice than in control littermates (Figures 2A and S2F) , suggesting that the VAChT gene becomes aberrantly upregulated in Chx10-null neurons.
Overall, our data demonstrate that Chx10 is critical for the development of V2aINs and that without Chx10, MN gene expression and development are also perturbed.
Chx10 Triggers V2a Fate, while Suppressing MN Fate, through Its DNA-Binding Activity Electroporation of Chx10 alone triggered the formation of ectopic Sox14 + V2aINs in the developing chick spinal cord (Figure 3A) . While Lhx3 failed to induce V2aINs in MN area, the expression of Chx10 led to effective generation of V2aINs in MN area ( Figures 1B and 3A) . Chx10 also induced the expression of Shox2 and VGlut2 in MN area ( Figure 3A) . These results suggest that Chx10 alone is sufficient to induce V2aIN fate.
To test whether Chx10 converts presumptive MNs to V2aINs, we examined the generation of MNs in the neural tube electroporated with Chx10. Upon the expression of Chx10, the number of Hb9 + MNs and Isl1 + MNs decreased by 30% and 46%, respectively ( Figures 3B, 3C , and S3). Likewise, the expression of VAChT, a cholinergic gene, was reduced by Chx10 ( Figure 3B ). Thus, Chx10 triggers the generation of V2aINs at the expense of MNs in the ventral spinal cord.
To test whether the DNA-binding activity of Chx10 is required to activate V2aIN differentiation and inhibit MN fate, we employed the DNA-binding defective Chx10-N51A mutant (Dorval et al., 2005) . Despite a high level of expression of Chx10-N51A comparable to that of Chx10 wild-type, Chx10-N51A neither induced ectopic V2aINs nor inhibited differentiation of MNs (Figure 3) . These results suggest that binding to Chx10-response elements is required for Chx10 to drive V2aIN fate acquisition and suppress MN differentiation.
Taken together, our data demonstrate that Chx10 is a critical and active regulator of V2aIN identity.
Chx10 Effectively Triggers V2a Fate and Suppresses MN Fate in Differentiating Embryonic Stem Cells
To investigate whether Chx10 can actively promote V2aIN fate while concomitantly repressing MN identity, we utilized a wellestablished differentiation paradigm of mouse embryonic stem cells (ESCs), which directs ESCs to acquire MN identity (Wichterle et al., 2002) . To monitor the activity of Chx10 in this context, we generated doxycycline (Dox)-dependent Chx10-inducible ESCs (Chx10-ESCs), in which Chx10 coding sequences were inserted downstream of the tetracycline response element (TRE) and the reverse tetracycline transactivator (rtTA) was integrated into the constitutively active Rosa26 locus ( Figure 4A ). In Chx10-ESCs, the expression of FLAG epitope-tagged Chx10 was robustly induced by Dox treatment ( Figure 4B ). We differentiated Chx10-ESCs to MNs following the protocol (Wichterle et al., 2002) , in the presence of vehicle or Dox (i.e., Chx10 expression) ( Figures 4A and 4C ). Chx10-ESCs differentiated to MNs when incubated with vehicle, as revealed by strong Hb9-expression ( Figure 4C ). However, they failed to differentiate into Hb9 + MNs when Chx10 expression was induced by Dox ( Figure 4C ). Several remaining Hb9 + MNs in the Dox-treated condition expressed low levels of Chx10 and exhibited a complementary pattern of expression between Chx10 and Hb9 ( Figure 4C ). These results indicate that Chx10 inhibits differentiation of ESCs to MNs.
To systematically investigate the effect of Chx10 on MN differentiation, we performed RNA-sequencing (seq) analyses in ESC-derived MNs and analyzed the transcriptome changes triggered by Chx10 expression (i.e., Dox treatment) ( Figure 4D ; Table S1 ). Chx10 led to a significant change in the level of 533 genes (fold change 1.5, p % 0.01). Among these genes, 68% (363 genes) were downregulated by Chx10, while 32% (170 genes) were upregulated. Many MN genes, such as Hb9, Isl1, Isl2, choline acetyltransferase (ChAT), and VAChT were suppressed by Chx10. The expression of interneuron genes, such as Dbx1 and Olig3 that direct V0 and dorsal interneuron dI1-3 fates, respectively, was repressed. Chx10 strongly induced Sox14, a V2aIN gene, by $149-fold. Other known V2aIN genes, Sox21 and VGluT2, were also upregulated by Chx10. Chx10-directed induction of V2aIN genes and repression of MN and non-V2aIN genes were confirmed by independent qRT-PCR analyses ( Figure 4E ). These genome-wide transcriptome analyses establish that Chx10 can actively promote V2aIN fate, while suppressing MN development, in the cells that are directed to acquire MN fate.
Dual Regulatory Modes of Chx10 to Control V2aIN and MN Fates
Chx10 acts as both transcriptional repressor and activator in chick neuronal cultures (Dorval et al., 2005) . To test whether Chx10 acts as a transcriptional repressor or activator to drive V2aIN fate and suppress MN identity, we generated constitutive activator and repressor forms of Chx10 by fusing the C-terminal half of Chx10, which contains the DNA-binding HD, to VP16 transcriptional activation domain or Engrailed transcriptional repression domain (EnR) ( Figure 5A ). Similarly to Chx10 wild-type, EnR-Chx10 triggered the formation of ectopic V2aINs in both dorsal neural tube and MN area, as indicated by ectopic upregulation of Sox14, Shox2, and VGluT2 ( Figure 5B ). However, expression of VP16-Chx10 resulted in a drastic reduction of Sox14 + V2aINs ( Figure 5B ).
Consistently, expression of VGluT2 and Sox14 was repressed by VP16-Chx10 ( Figure 5B ), suggesting that VP16-Chx10 functions as a dominant negative in the V2aIN differentiation pathway. Therefore, Chx10 functions as a transcriptional repressor to drive V2a fate specification. Expression of EnR-Chx10 or VP16-Chx10 led to a decrease of Hb9 + /Isl1 + MNs in chick neural tube ( Figure 5B ). Similarly, both fusions reduced VAChT expression ( Figure 5B ). Therefore, Chx10 inhibits MN development independently of its transcriptional activity, which is distinct from the requirement of its transcriptional repression activity in promoting V2aIN fate.
Identification of Chx10-Bound Genomic Elements
Our findings suggest that Chx10 suppresses MN genes by competitively binding to the response elements bound and activated by MN fate-determining transcription factors such as the Isl1-Lhx3-complex. Furthermore, the Isl1-Lhx3-binding motif is similar to the optimal binding site of Chx10, identified in vitro (Lee et al., 2008 (Lee et al., , 2013 Wilson et al., 1993) . Thus, Chx10 may compete with the Isl1-Lhx3-complex to bind to an important set of MN genes, thereby inhibiting their activation by Isl1-Lhx3. To test this hypothesis in an unbiased genome-wide manner, we performed chromatin immunoprecipitation (ChIP)-seq analyses in Chx10-ESCs and mapped Chx10-binding genomic loci (Table S2) . Among the 363 genes that were downregulated by Chx10, 232 genes were associated with Chx10-bound ChIP-seq peaks (Table S3 ), suggesting that this set of genes are likely direct target genes of Chx10. In support of our hypothesis, these genes included MN genes, including Hb9, Isl1, ChAT, and VAChT (Table S3) . Non-V2aIN genes, such as Dbx1, Olig3, and Otp also recruited Chx10 ( Figure S4 ; Table  S3 ) and became downregulated by Chx10 ( Figures 4D and 4E ), suggesting that Chx10 represses a subset of non-V2aIN genes via its repressor activity. Chx10 also bound the promoter of the Vsx1 gene ( Figure S5A ). Chx10 and Vsx1 are the only paired-like HD genes with the CVC domain in the mouse genome (Chow et al., 2001) . Vsx1 is expressed in differentiating V2 interneurons in zebrafish (Kimura et al., 2008) . Vsx1 displayed similar expression pattern in the mouse spinal cord, but appeared to be downregulated in more laterally located, mature Chx10 + V2aINs ( Figure S5C ). Combined with our RNA-seq and RT-PCR results that Chx10 represses the expression of Vsx1 ( Figures 4D and S5B although the activity of Vsx1 in inducing ectopic Sox14 + cells was weaker than that of Chx10 in the dorsal spinal cord ( Figures  S5D and 3A) . These results indicate the functional redundancy between Chx10 and Vsx1 in directing V2a specification and inhibiting MN differentiation. The redundant action and regulatory feedback between Chx10 and Vsx1 likely contributes to the gene network in V2a-MN development. Next, we compared Chx10-bound ChIP-seq peaks to Isl1-Lhx3-bound ChIP-seq peaks (Lee et al., 2013) and identified 927 genomic regions that recruit both Chx10 and Isl1-Lhx3 (Figure 6A ; Table S4 ). To identify DNA motifs that are significantly enriched in this set of ChIP-seq peaks, we analyzed the sequences of the 927 genomic regions using two complementary motif discovery algorithms, MEME and DREME . Both algorithms discovered an almost identical motif as the most significantly enriched DNA sequences ( Figure 6A ). This motif resembles the previously identified binding sites of Isl1-Lhx3 and Chx10 ( Figure 6A ) (Lee et al., 2008 (Lee et al., , 2013 Wilson et al., 1993) and is enriched in the center of the common peaks for Chx10 and Isl1-Lhx3 ( Figure 6B ). Thus, this motif likely serves as a direct binding element for both Chx10 and Isl1-Lhx3.
Overall, we identified a set of direct target genes for Chx10, which include many known MN genes. Furthermore, these analyses demonstrate that Chx10 share many genomic target elements with Isl1-Lhx3.
Chx10 and Isl1-Lhx3 Bind the Same Genomic Regions Linked to MN Genes
Our studies suggest a model that, during V2aIN differentiation, Chx10 represses important MN genes by competitively binding to the response elements that are occupied and activated by Isl1-Lhx3 in MNs ( Figure 7E) . To identify the genes that are coregulated by Chx10 and Isl1-Lhx3 via the same regulatory elements, we compared Chx10/Isl1-Lhx3 common ChIP-seq peaks with two RNA-seq data sets, which identified transcriptome changes upon expression of Chx10 or Isl1-Lhx3 (Table S1 ) (Lee et al., 2012) . These analyses revealed 12 genes, which are associated with Chx10/Isl1-Lhx3-common ChIP-seq peaks and are downregulated by Chx10, while being upregulated by Isl1-Lhx3 ( Figures 6C, 6D , and S6A). These 12 genes have been implicated in MN development or neuronal functions (see Discussion).
To further test our model ( Figure 7E ), we investigated the in vivo recruitment of Isl1-Lhx3 and Chx10 to their common binding elements in Hb9, LMO1, and Slit3/miR218-2 loci. The endogenous Isl1, Lhx3, and Chx10 proteins were recruited to each of the common binding sites in the developing spinal cord, as shown by ChIP in E12.5 mouse spinal cord ( Figure 6E ). Next, we monitored the binding of Isl1-Lhx3 to Hb9, LMO1, and Slit3/miR218-2 loci in the presence of Chx10 wild-type or Chx10-N51A in P19 cells. Chx10 wild-type, but not Chx10-N51A, inhibited the recruitment of Isl1-Lhx3 to their common binding loci (Figure S6B) . While Hb9 and miR-218 are expressed in MNs and induced by Isl1-Lhx3 (Tanabe et al., 1998; Thaler et al., 2002; Thiebes et al., 2015) , the regulation of Lmo1 and Slit3 genes in the neural tube remains unknown. In the developing spinal cord, the expression of LMO1 and Slit3 were highly and specifically induced as MNs emerged from the progenitor zone (see unelectroporated control sides in Figure 6F ). Interestingly, Isl1-Lhx3 ectopically upregulated LMO1 and Slit3 in the dorsal spinal cord, whereas Chx10 inhibited their expression in MNs (Figure 6F) . As expected, both EnR-Chx10 and VP16-Chx10 suppressed LMO1 and Slit3 expression in MNs ( Figure 6F ). These results support our model that Chx10 effectively represses MN genes, at least in part, by competing with Isl1-Lhx3 for the same response elements ( Figure 7E ).
To investigate how Chx10 and Isl1-Lhx3 influence the transcriptional activity of their common target genomic elements, we generated a luciferase reporter linked to a Chx10/Isl1-Lhx3-bound genomic element upstream of the Lmo1 gene ( Figure 6D ). We monitored how the expression of Isl1-Lhx3, Chx10, or both affects the transcriptional activity of the Lmo1 genomic element using the Lmo1::Luc reporter in P19 mouse embryonic cells ( Figure 6G ). While Isl1-Lhx3 potently activated the Lmo1 element, Chx10 repressed its activity. Furthermore, Chx10 inhibited Isl1-Lhx3-dependent activation of the reporter in a DNA-binding activity-dependent manner. VP16-Chx10 activated the Lmo1::Luc, while EnR-Chx10 suppressed it (Figure S6C) , suggesting that VP16-Chx10 is capable of DNA-binding and likely functions as DNA-binding competitor of Isl1-Lhx3 in MN inhibition (Figures 5 and 6F ). Chx10 acted similarly on the Hb9::Luc reporter ( Figure 6H ).
Our data establish that, during V2aIN specification, Chx10 represses a subset of MN genes, which are activated by Isl1-Lhx3 in MNs via shared response elements. Figure 7A ) (Arber et al., 1999; . We hypothesized that the aberrant upregulation of Chx10 contributes to the reduction of MNs, and it also Figure 7E ). This gene network for V2aINs and MNs provides important insights into a fundamental question in developmental biology; how two closely related cell fates are specified and maintain disparate cell identities despite the expression of common transcriptional regulators during organogenesis. Many transcriptional repressors contribute to patterning, cell fate specification, differentiation, and organogenesis in various developmental contexts. Thus, the mechanisms by which Chx10 promotes and consolidates V2aIN fate are applicable to many other developmental contexts that require the action of transcriptional repressors. Our study revealed that the mechanism by which Lhx3 directs the V2aIN fate is distinct from the mechanism by which Isl1-Lhx3 triggers the MN fate. The Isl1-Lhx3-complex drives MN differentiation by directly binding and inducing a wide range of MN genes, whereas the potential of Lhx3 to trigger V2aIN differentiation is mediated largely by its downstream target Chx10, as demonstrated by our results showing that Lhx3 fails to trigger V2aIN generation without Chx10 (Figures 1B and 7E ). We also found that Chx10 triggers the formation of ectopic V2aINs without upregulating Lhx3 in the neural tube ( Figure 3A , data not shown), suggesting that Chx10 does not need Lhx3 to trigger V2aIN fate. Furthermore, Chx10 is much more effective in inducing V2aIN fate than Lhx3 in the MN area. Lhx3 is unable to induce V2aIN genes in the MN domain, most likely due to the presence of Isl1 and LMO4, which block the formation of the Lhx3-complex that upregulates Chx10 ( Figure 1A ) (Lee et al., 2008; Thaler et al., 2002) . However, Chx10 effectively drives V2aIN differentiation in the MN area ( Figure 3A ). (Figures 7C and 7D ). These data reinforce the idea that Chx10 is an active driver of V2aIN fate. They also indicate that the main function of Hb9 with regard to inhibition of V2aIN fate is to suppress Chx10. Indeed, we have previously found that Hb9 directly binds and represses Chx10 (Lee et al., 2008) . The action of Chx10 in segregating MN and V2aIN fates is expected to be particularly important in V2aINs derived from the progenitor cells located in the boundary between pMN and p2 domains ( Figure 7E ). The progenitors at the borderline have to interpret slightly different concentration of Shh and take on either pMN or p2 identities. Without Chx10, presumptive V2aINs may upregulate MN genes, but fail to observe MN-periphery boundaries and get lost via the motor exit point, contributing to the reduction of V2aINs.
Our results revealed that Chx10 primarily functions as a transcriptional repressor to induce V2aIN fate, whereas Chx10 inhibits MN fate regardless of its inherent transcriptional activity (Figures 5, 6F , and 7F). Chx10 competes with Isl1-Lhx3 by binding the shared response elements linked to several MN genes. Consistently, our comparative ChIP-seq analyses identified common binding sites for Isl1-Lhx3 and Chx10. Many of these sites control genes that play a role in MN fate specification, differentiation, and function. Hb9, LMO, and miR-218 are important to establish MN identity and MN-specific gene expression pattern (Amin et al., 2015; Arber et al., 1999; Lee et al., 2008; Thiebes et al., 2015) . Slit-Robo and semaphorin-neuropilin signaling pathways are important for MN cell body positioning and motor axon guidance (Bai et al., 2011; Bron et al., 2007; . FGF, NCAM, and NGFR signaling pathways play a role in MN survival (Garcè s et al., 2000; Nishimune et al., 2005; Xie et al., 2003) . Lix1 is deleted in autosomal-recessive spinal muscular atrophy, a MN disease (Fyfe et al., 2006) . These findings strongly support our model that Isl1-Lhx3 and Chx10 commonly target a range of MN genes and regulate their transcription oppositely ( Figure 7E ). Given that we used stringent cutoff in comparative analyses of two ChIPseq and two RNA-seq data sets, the common target MN genes of Isl1-Lhx3 and Chx10 are likely to be more than the 12 genes identified in this study.
Chx10 is likely to mobilize transcriptional activators to upregulate V2aIN genes, given that it acts as a transcriptional repressor in directing V2aIN fate. V2aIN-specific transcription factors downstream of Chx10, such as Sox14 may function as activators to upregulate V2aIN genes, forming a positive feedback loop to reinforce V2aIN fate choice. Alternatively, a relatively widely expressed neuronal transcription factor may be responsible for activating V2aIN genes and Chx10 may be important to suppress the inhibitor of this transcriptional activator.
Importantly, our findings represent a generalizable phenomenon likely occurring during the organogenesis of many different tissues that require segregation of cell fates derived from closely related progenitor pools during development.
EXPERIMENTAL PROCEDURES
Mouse Lines
The Chx10 orJ/orJ and Hb9 À/À mutant mice have been previously described . Chx10 orJ/orJ mice were obtained from the Jackson Laboratories. Animals were housed and cared for according to institutional animal care and use committee guidelines.
Chick in Ovo Electroporation, Immunohistochemistry, and In Situ Hybridization Assays
In ovo electroporation, immunohistochemistry, and in situ hybridization assays were performed as previously described on chick or mouse embryos cryosectioned at 13-18 mm (Lee et al., 2004) . The following primary antibodies were used: mouse anti-Hb9/MNR2 (on chick tissue, DSHB, 5C10), rabbit anti-Hb9 (on mouse tissue) , rabbit anti-Isl1 (K5) , guinea pig anti-Lhx3 , guinea pig anti-Chx10 (Lee et al., 2008; , rabbit anti-Chx10 (homemade), guinea pig anti-Sox14 (homemade), rat anti-Gata3 (Absea Biotechnology), rabbit antiEvx1 , mouse anti-FLAG (Sigma), and rabbit antiactivated Caspase 3 (Cell Signaling Technology, #9661). We generated the antibodies against Sox14 and Chx10 using the proteins corresponding to amino acids 1-154 of mouse Chx10 protein or 67-243 of chick Sox14 (NM_204761).
Culture, Generation, and Differentiation of Chx10-ESCs Chx10-ESCs were generated from the A172LoxP ESC line . For MN differentiation assays, Chx10-ESC aggregates (embryoid bodies, EBs) were treated with all trans retinoic acid (0.5 mM) and a Shh agonist purmorphamine (1 mM; Calbiochem) for 2 days and then cultured with either Dox (2 mg/ml) or vehicle for additional 2 to 3 days before the analyses.
RT-PCR, RNA-Seq, and ChIP-Seq Assays Total RNA was extracted using RNeasy Mini Kit (QIAGEN) and reverse transcription was performed using SuperScript III (Invitrogen). RNA-seq libraries were prepared according to the Illumina TruSeq protocol, validated using the bioanalyzer and real-time PCR, and then sequenced on the Illumina HiSeq 2000. For ChIP-seq, ChIP DNA samples from Chx10-ESC-derived MNs were prepared for sequencing according to the Illumina protocol and sequenced on the Illumina HiSeq 2000. The peak calling was conducted with MACS software . MEME-ChIP Suite and TOMTOM algorithm was used for motif analysis.
Statistical Analysis
Statistical differences were determined by two-tailed Student's t test. Statistical significance is displayed as *p < 0.05, **p < 0.01, *** p < 0.005, and ns (nonsignificant).
ACCESSION NUMBERS
The accession number for the ChIP-seq and RNA-seq data reported in this paper is NCBI GEO: GSE83874. The combined analyses of Chx10-bound ChIPseq and Isl1-Lhx3-bound ChIPseq datasets. 927 genomic regions were found to overlap between Chx10-bound ChIPseq peaks and Isl1-Lhx3-bound ChIPseq peaks.
SUPPLEMENTAL INFORMATION
SUPPLEMENTAL PROCEDURES
Mouse lines
As a Chx10-deficient mouse model, we chose a naturally occurring Chx10 mutant ocular retardation (Chx10 orJ/orJ ), in which a cytosine residue in exon 3 of the Chx10 gene is converted to an adenine . This point mutation creates a premature stop codon in the DNA-binding domain of Chx10, resulting in the synthesis of a non-functional truncated Chx10 protein composed of amino acids 1 to 361, which lacks the DNA-binding domain of Chx10 and appears to be quickly degraded. Chx10 orJ/orJ mice were obtained from the Jackson Laboratories (Bar Harbor, ME). Hb9 -/-mutant mice have been previously described . Animals were housed and cared for according to IACUC guidelines. For timed mating, females were considered to be at 0.5 days of gestation (E0.5) at noon the day a vaginal plug was detected.
Chick in ovo electroporation
In ovo electroporation was performed as previously described (Lee et al., 2004) .
Chick eggs (McIntyre Farms, Portland, OR, USA) were incubated in a humidified chamber. DNA constructs were injected into the lumen of chick embryonic spinal cords at HH stage 10 to 12. Electroporation was performed using a square wave electroporator (BTX).
Immunohistochemistry and in situ hybridization assay
The mouse embryos were collected at various stages, fixed in 4% paraformaldehyde, sunk in 30% sucrose, and embedded in OCT for cryosectioning and subsequent analyses. The chick embryos were harvested 3 days post-electroporation at HH stage 24-27 and cryosectioned at 13 µm.
Immunohistochemistry was performed using 0.1% Fish gelatin (Sigma Aldrich, Saint Louis, MO) blocking buffer with overnight incubation at 4°C, using the following primary antibodies: Mouse anti-Hb9/MNR2 (on chick tissue, DSHB, 5C10), rabbit anti-Hb9 (on mouse tissue) , rabbit anti-Isl1 (K5) , guinea pig anti-Lhx3 , guinea pig anti-Chx10 (Lee et al., 2008; , rabbit anti-Chx10 were treated with all trans retinoic acid (0.5 µM) and a Shh agonist purmorphamine (1 µM; Calbiochem) for two days. Then, the EBs were cultured with either doxycycline (2 µg/mL) or vehicle for additional two to three days before the analyses.
RT-PCR and RNAseq assays
Total RNA was extracted using RNeasy Mini kit (Qiagen) and reverse transcription was performed using SuperScript III (Invitrogen). Those PF reads were then aligned to NCBI37/mm9 genome using Tophat (version 1.3.3) (Trapnell et al., 2009 ) with the guidance of mm9 RefSeq gene annotations. RefSeq annotations in GTF format were downloaded from UCSC Genome Browser. In order to eliminate the artifacts of multi-hit reads, only the reads mapped to a single unique locus on the genome were kept for further analysis. Some entries in GTF were manually corrected. The number of reads assigned to each individual transcript was counted by the tools in DEXSeq, an R package, with the guidance of RefSeq annotations. The count data were normalized by median. The differentially expressed genes were determined by a negative binomial distribution model in DESeq package (Anders and Huber, 2010) .
ChIPseq analyses
Chx10-ESCs were differentiated into MNs in the presence of all trans retinoic acid and purmorphamine following EB formation, as described above, and Chx10 expression was induced by treating the cells with Dox (2 µg/mL) for 2 days.
Approximately 4×10 6 cells were washed with PBS buffer, fixed by 1% formaldehyde for 10 min at room temperature, and quenched with 125 mM glycine. Cells were washed with Buffer I (0.25% Triton X-100, 10 mM EDTA, 0.5 mM EGTA, 10 mM Hepes, pH 6.5) and Buffer II (200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 10 mM Hepes, pH 6.5) sequentially. Then, cells were lysed with lysis buffer (0.5% SDS, 5 mM EDTA, 50 mM Tris·HCl, pH 8.0, protease inhibitor mixture) and were subjected to sonication for DNA shearing. Next, cell lysates were diluted 1:10 in ChIP buffer (0.5% Triton X-100, 2 mM EDTA, 100 mM NaCl, 50 mM Tris·HCl, pH 8.0, protease inhibitor mixture) and, for immunoclearing, were incubated with IgG and protein A agarose beads for 1 hour at 4 °C.
Supernatant was collected after quick spin and incubated with α-FLAG antibody (Sigma) and protein A agarose beads to precipitate Flag-Chx10/chromatin complex overnight at 4 °C. After pull-down of Flag-Chx10/chromatin/antibody complex with protein A agarose beads, the beads were washed with TSE I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris·HCl, pH 8.0, 150 mM NaCl), TSE II (same components as in TSE I except 500 mM NaCl), and Buffer III (0.25 M LiCl, 1% Nonidet P-40, 1% deox-ycholate, 1 mM EDTA, 10 mM Tris·HCl, pH 8.0) sequentially for 10 min at each step. Then the beads were washed with Tris-EDTA (TE) buffer three times. FLAG-Chx10/chromatin complexes were eluted in elution buffer (1% SDS, 1 mM EDTA, 0.1 M NaHCO 3 , 50 mM Tris·HCl, pH 8.0) and de-crosslinked by incubating at 65 °C overnight. Eluate was incubated at 50 °C for more than 2 hours with Proteinase K. Next, DNA was purified with Phenol/chloroform and DNA pellet was precipitated by ethanol and resolved in water. ChIP DNA samples were prepared for sequencing according to the Illumina protocol, and sequenced on the Illumina HiSeq 2000.
The sequence reads generated from Illumina GApipeline were mapped to mouse reference genome (NCBI37, mm9) using Bowtie2 (v2.2.3) with default parameters. If several reads had the exact same sequence and direction, only one copy was kept for the analysis to minimize the artifacts introduced by PCR amplification during sample preparation. The peak calling was conducted with collected gene annotation from the UCSC genome browser (mm9). To associate each peak to genes, the potential target RefSeq genes were identified with the following criterion: at least one ChIP-Seq peak located from 2 kb upstream or downstream of a gene. If no gene is found within the selected range from a peak, the nearest two genes to the peak were chosen as potential targets. MEME-ChIP Suite was used for motif analysis with some modifications based on its standard protocol.
The sequences of each peak were defined by extending 250 bp from the middle of the summits of Chx10-bound and Isl1-Lhx3-bound ChIPseq peaks (total 927 peaks) to both sides, and the 500 bp sequences were extracted from the UCSC genome browser mm9 assembly. The motifs identified by MEME and DREME were compared to a database of known transcription factors (TF) (JASPAR_CORE_2009.meme) using TOMTOM algorithm that is also included in the MEME-ChIP Suite. The p-values in motif analyses were calculated by the corresponding programs in MEME suite.
To visualize the frequency of each motif in relation to the summit of the Chx10/Isl1-Lhx3-bound peaks, a graph of positional distribution was plotted. The number of sites for each motif was binned in size of 10 according to its relative distance to the summit of the peaks, which was set as 0.
ChIP assays
To perform the ChIP assays in mouse embryonic tissues, we dissected E12.5
spinal cords. The micro-dissected spinal cords from 5-12 embryos were combined for each ChIP reaction with a specific antibody. The tissues were dissociated completely before the ChIP process. Next, cells were washed with Buffer I (0.25% Triton X-100, 10 mM EDTA, 0.5 mM EGTA, 10 mM Hepes, pH 6.5) and Buffer II (200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 10 mM Hepes, pH 6.5) sequentially. Then, cells were lysed with lysis buffer (0.5% SDS, 5 mM EDTA, 50 mM Tris·HCl, pH 8.0, protease inhibitor mixture) and were subjected to sonication for DNA shearing. Next, cell lysates were diluted 1:10 in ChIP buffer
